List of Tables
Table 1. Personalizing Cancer Drugs Market Trends
Table 2. Personalizing Cancer Drugs Market Drivers & Opportunity
Table 3. Personalizing Cancer Drugs Market Challenges
Table 4. Personalizing Cancer Drugs Market Restraints
Table 5. Global Personalizing Cancer Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Personalizing Cancer Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Personalizing Cancer Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Personalizing Cancer Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Personalizing Cancer Drugs
Table 10. Global Personalizing Cancer Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalizing Cancer Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Personalizing Cancer Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Personalizing Cancer Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Personalizing Cancer Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Personalizing Cancer Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Personalizing Cancer Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Personalizing Cancer Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Personalizing Cancer Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Personalizing Cancer Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Personalizing Cancer Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Personalizing Cancer Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Personalizing Cancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Personalizing Cancer Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Personalizing Cancer Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Personalizing Cancer Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Personalizing Cancer Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Personalizing Cancer Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Personalizing Cancer Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Personalizing Cancer Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Bayer Basic Information List
Table 32. Bayer Description and Business Overview
Table 33. Bayer Personalizing Cancer Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Bayer (2019-2024)
Table 35. Bayer Recent Developments
Table 36. GlaxoSmithKline Basic Information List
Table 37. GlaxoSmithKline Description and Business Overview
Table 38. GlaxoSmithKline Personalizing Cancer Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Personalizing Cancer Drugs Business of GlaxoSmithKline (2019-2024)
Table 40. GlaxoSmithKline Recent Developments
Table 41. Novartis Basic Information List
Table 42. Novartis Description and Business Overview
Table 43. Novartis Personalizing Cancer Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Novartis (2019-2024)
Table 45. Novartis Recent Developments
Table 46. Sanofi Basic Information List
Table 47. Sanofi Description and Business Overview
Table 48. Sanofi Personalizing Cancer Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Sanofi (2019-2024)
Table 50. Sanofi Recent Developments
Table 51. Pfizer Basic Information List
Table 52. Pfizer Description and Business Overview
Table 53. Pfizer Personalizing Cancer Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Pfizer (2019-2024)
Table 55. Pfizer Recent Developments
Table 56. Amgen Basic Information List
Table 57. Amgen Description and Business Overview
Table 58. Amgen Personalizing Cancer Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Amgen (2019-2024)
Table 60. Amgen Recent Developments
Table 61. Merck Basic Information List
Table 62. Merck Description and Business Overview
Table 63. Merck Personalizing Cancer Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Merck (2019-2024)
Table 65. Merck Recent Developments
Table 66. Bristol-Myers Squibb Basic Information List
Table 67. Bristol-Myers Squibb Description and Business Overview
Table 68. Bristol-Myers Squibb Personalizing Cancer Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Bristol-Myers Squibb (2019-2024)
Table 70. Bristol-Myers Squibb Recent Developments
Table 71. Celgene Corporation Basic Information List
Table 72. Celgene Corporation Description and Business Overview
Table 73. Celgene Corporation Personalizing Cancer Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Celgene Corporation (2019-2024)
Table 75. Celgene Corporation Recent Developments
Table 76. Ariad Pharmaceuticals Basic Information List
Table 77. Ariad Pharmaceuticals Description and Business Overview
Table 78. Ariad Pharmaceuticals Personalizing Cancer Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Ariad Pharmaceuticals (2019-2024)
Table 80. Ariad Pharmaceuticals Recent Developments
Table 81. Eli Lilly Basic Information List
Table 82. Eli Lilly Description and Business Overview
Table 83. Eli Lilly Personalizing Cancer Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Eli Lilly (2019-2024)
Table 85. Eli Lilly Recent Developments
Table 86. Hoffmann-La Roche Basic Information List
Table 87. Hoffmann-La Roche Description and Business Overview
Table 88. Hoffmann-La Roche Personalizing Cancer Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Hoffmann-La Roche (2019-2024)
Table 90. Hoffmann-La Roche Recent Developments
Table 91. Boehringer Ingelheim Basic Information List
Table 92. Boehringer Ingelheim Description and Business Overview
Table 93. Boehringer Ingelheim Personalizing Cancer Drugs Products, Services and Solutions
Table 94. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Boehringer Ingelheim (2019-2024)
Table 95. Boehringer Ingelheim Recent Developments
Table 96. Johnson and Johnson Basic Information List
Table 97. Johnson and Johnson Description and Business Overview
Table 98. Johnson and Johnson Personalizing Cancer Drugs Products, Services and Solutions
Table 99. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Johnson and Johnson (2019-2024)
Table 100. Johnson and Johnson Recent Developments
Table 101. Teva Pharmaceuticals Basic Information List
Table 102. Teva Pharmaceuticals Description and Business Overview
Table 103. Teva Pharmaceuticals Personalizing Cancer Drugs Products, Services and Solutions
Table 104. Revenue (US$ Million) in Personalizing Cancer Drugs Business of Teva Pharmaceuticals (2019-2024)
Table 105. Teva Pharmaceuticals Recent Developments
Table 106. Key Raw Materials Lists
Table 107. Raw Materials Key Suppliers Lists
Table 108. Personalizing Cancer Drugs Downstream Customers
Table 109. Personalizing Cancer Drugs Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Personalizing Cancer Drugs Product Picture
Figure 2. Global Personalizing Cancer Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Personalizing Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Personalizing Cancer Drugs Report Years Considered
Figure 5. Global Personalizing Cancer Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Personalizing Cancer Drugs Revenue in 2023
Figure 7. Personalizing Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Immunotherapy Picture
Figure 9. Targeted Therapy Picture
Figure 10. Chemotherapy Picture
Figure 11. Hormone Therapy Picture
Figure 12. Others Picture
Figure 13. Global Personalizing Cancer Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Personalizing Cancer Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Breast Cancer
Figure 16. Product Picture of Blood Cancer
Figure 17. Product Picture of Gastrointestinal Cancer
Figure 18. Product Picture of Prostate Cancer
Figure 19. Product Picture of Skin Cancer
Figure 20. Product Picture of Lung Cancer
Figure 21. Product Picture of Others
Figure 22. Global Personalizing Cancer Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Personalizing Cancer Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 24. North America Personalizing Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 25. North America Personalizing Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 26. Europe Personalizing Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. Europe Personalizing Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. Asia Pacific Personalizing Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. Asia Pacific Personalizing Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. South America Personalizing Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 31. South America Personalizing Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 32. Middle East & Africa Personalizing Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 33. Middle East & Africa Personalizing Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 34. Key Countries/Regions Personalizing Cancer Drugs Sales Value (%), (2019-2030)
Figure 35. United States Personalizing Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 36. United States Personalizing Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 37. United States Personalizing Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 38. Europe Personalizing Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 39. Europe Personalizing Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 40. Europe Personalizing Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 41. China Personalizing Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 42. China Personalizing Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 43. China Personalizing Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 44. Japan Personalizing Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. Japan Personalizing Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. Japan Personalizing Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. South Korea Personalizing Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. South Korea Personalizing Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. South Korea Personalizing Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. Southeast Asia Personalizing Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 51. Southeast Asia Personalizing Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 52. Southeast Asia Personalizing Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 53. India Personalizing Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 54. India Personalizing Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 55. India Personalizing Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 56. Personalizing Cancer Drugs Industrial Chain
Figure 57. Personalizing Cancer Drugs Manufacturing Cost Structure
Figure 58. Channels of Distribution (Direct Sales, and Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
